Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

prnewswire.com
LLY

Tinnitus Treatment Landscape Set for Significant Market Upswing During Forecast Period (2026-2036) as Need for Effective Therapies Intensifies | DelveInsight

prnewswire.com
SPRC REGN LLY

New Study Shows Scripps Patients Maintained Weight Loss After Reducing GLP-1 Treatment Frequency

globenewswire.com
LLY NVO

SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic

globenewswire.com
NVS MRK BMY LLY ABBV JNJ AZN GILD BIIB REGN AMGN VRTX

EXPLORING THE FUTURE OF CONNECTIVITY, AI, AND DISRUPTION WITH T-MOBILE CEO SRINI GOPALAN

prnewswire.com
TROW TMUS GE NYT ISRG NVDA XOM BX LLY

Biocomputing Market Research Report 2026: Transitioning from Experimental Research to Early Enterprise Deployment Across Healthcare and Industrial Biology

globenewswire.com
LLY AMGN

Ivim Health GLP-1 Weight Loss Program: Individualized Dosing, Pricing, and What Consumers Should Know in 2026

globenewswire.com
LLY NVO

Morgan & Morgan Secures $4.7 Million Verdict After Defeating Lowball $75,000 Offer in Orlando Trucking Crash

globenewswire.com
GOOG META LLY

Solve M.E. Funds GLP-1 and Immune Target Studies to Accelerate ME/CFS and Long Covid Breakthroughs

prnewswire.com
NVO LLY

Bakar Labs Helps Companies Raise More Than $1 Billion in Its First Four Years of Operation

accessnewswire.com
AMGN ABBV JNJ LLY